PHARMACYTE BIOTECH, INC. Repayments of Other Debt
PHARMACYTE BIOTECH, INC. (PMCB) reported Repayments of Other Debt of $0 for the 12-month period ending 2023-04-30, per its 10-K filed 2023-07-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2023-07-31
- PHARMACYTE BIOTECH, INC. repayments of other debt for the quarter ending 2022-04-30 was $50.80K.
- PHARMACYTE BIOTECH, INC. repayments of other debt for the quarter ending 2022-01-31 was $0.00, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. repayments of other debt for the quarter ending 2021-04-30 was -$50.80K.
- PHARMACYTE BIOTECH, INC. repayments of other debt for the quarter ending 2021-01-31 was $38.17K.
- PHARMACYTE BIOTECH, INC. repayments of other debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PHARMACYTE BIOTECH, INC. repayments of other debt for fiscal 2022 was $50.80K, a 18.63% decline from fiscal 2021.
- PHARMACYTE BIOTECH, INC. repayments of other debt for fiscal 2021 was $62.44K.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 6 month | Repayments of Other Debt 9 month | Repayments of Other Debt 12 month |
|---|---|---|---|---|
| 2023-04-30 | $0.00 10-K · filed 2023-07-31 | |||
| 2022-04-30 | $50.80K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | $50.80K derived: sum of 2 quarters · filed 2023-07-31 | $50.80K 10-K · filed 2023-07-31 | |
| 2022-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $0.00 10-Q · filed 2022-03-15 | ||
| 2021-10-31 | $0.00 10-Q · filed 2021-12-14 | |||
| 2021-04-30 | -$50.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | -$12.64K derived: sum of 2 quarters · filed 2022-07-28 | $62.44K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $38.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $113.25K 10-Q · filed 2022-03-15 | ||
| 2020-10-31 | $75.08K 10-Q · filed 2021-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |